← Open Payments lookup

JACOB LEVY: Open Payments

NPI 1710351515 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,892 in 77 payments from 17 companies in 2025. Trend: 2023 $1,185 · 2024 $1,454 · 2025 $1,892

Food & beverage: $1,807Education: $85
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.15$286
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$253
Amgen Inc.7$242
ABBVIE INC.8$200
AstraZeneca Pharmaceuticals LP8$158
Astellas Pharma US Inc3$137
Otsuka America Pharmaceutical, Inc.7$136
GlaxoSmithKline, LLC.6$133
Novo Nordisk Inc3$86
Renalytix AI, Inc.4$73

Products named: AUSTEDO XR, CAPLYTA, OTEZLA, VRAYLAR, TRELEGY ELLIPTA, BREZTRI, Ozempic, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT.

Industry payments across NY — which companies pay providers there.